FDA To Share Perspective On Polymorphic Forms In Abbreviated New Drug Applications - 6th Annual IQPC Polymorphism & ... (Medical News Today)
The FDA have confirmed they will be providing an insight into Polymorphic Forms in Abbreviated New Drug Applications (ANDAs). Andre Raw, Ph.

SyntheMed Announces FDA Clearance Of SinusShield(TM) (Medical News Today)
SyntheMed, Inc. (OTC Bulletin Board: SYMD) announced that it has received FDA 510(k) clearance to market SinusShield(TM), a bioresorbable membrane intended to prevent post-operative adhesions in nasal and sinus surgical procedures. There are approximately two million nasal and sinus procedures performed annually in the United States. Robert P.

FDA Approves Promacta(R) (Eltrombopag), The First Oral Medication To Increase Platelet Production For People With ... (Medical News Today)
GlaxoSmithKline (NYSE: GSK) announced that the United States Food and Drug Administration (FDA) granted accelerated approval for PROMACTA(R) (eltrombopag) for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.